Investigation of phase II metabolism of 11-hydroxy-Δ-9-tetrahydrocannabinol and metabolite verification by chemical synthesis of 11-hydroxy-Δ-9-tetrahydrocannabinol-glucuronide

被引:0
作者
Christoph Hassenberg
Florian Clausen
Grete Hoffmann
Armido Studer
Jennifer Schürenkamp
机构
[1] University Hospital Münster,Department of Forensic Toxicology, Institute of Legal Medicine
[2] Westfälische Wilhelms-Universität Münster,Organisch
来源
International Journal of Legal Medicine | 2020年 / 134卷
关键词
Cannabis; (−)-Δ-9-THC; (−)-11-OH-Δ-9-THC; Phase II metabolism; Synthesis of alcoholic (−)-11-OH-Δ-9-THC-glucuronide;
D O I
暂无
中图分类号
学科分类号
摘要
(−)-Δ-9-tetrahydrocannabinol ((−)-Δ-9-THC) is the main psychoactive constituent in cannabis. During phase I metabolism, it is metabolized to (−)-11-hydroxy-Δ-9-tetrahydrocannabinol ((−)-11-OH-Δ-9-THC), which is psychoactive, and to (−)-11-nor-9-carboxy-Δ-9-tetrahydrocannabinol ((−)-Δ-9-THC-COOH), which is psychoinactive. It is glucuronidated during phase II metabolism. The biotransformation of (−)-Δ-9-tetrahydrocannabinol-glucuronide ((−)-Δ-9-THC-Glc) and (−)-11-nor-9-carboxy-Δ-9-tetrahydrocannabinol-glucuronide ((−)-Δ-9-THC-COOH-Glc) is well understood, which is mainly due to the availability of commercial reference standards. Since such a standardized reference is not yet available for (−)-11-hydroxy-Δ-9-tetrahydrocannabinol-glucuronide ((−)-11-OH-Δ-9-THC-Glc), its biotransformation is harder to study and the nature of the glucuronide bonding—alcoholic and/or phenolic—remains unclear. Consequently, the aim of this study was to investigate the biotransformation of (−)-11-OH-Δ-9-THC-Glc in vitro as well as in vivo and to identify the glucuronide by chemically synthesis of a reference standard. For in vitro analysis, pooled human S9 liver fraction was incubated with (−)-Δ-9-THC. Resulting metabolites were detected by high-performance liquid chromatography system coupled to a high-resolution mass spectrometer (HPLC-HRMS) with heated electrospray ionization (HESI) in positive and negative full scan mode. Five different chromatographic peaks of OH-Δ-9-THC-Glc have been detected in HESI positive and negative mode, respectively. The experiment set up according to Wen et al. indicates the two main metabolites being an alcoholic and a phenolic glucuronide metabolite. In vivo analysis of urine (n = 10) and serum (n = 10) samples from cannabis users confirmed these two main metabolites. Thus, OH-Δ-9-THC is glucuronidated at either the phenolic or the alcoholic hydroxy group. A double glucuronidation was not observed. The alcoholic (−)-11-OH-Δ-9-THC-Glc was successfully chemically synthesized and identified the main alcoholic glucuronide in vitro and in vivo. (−)-11-OH-Δ-9-THC-Glc is the first reference standard for direct identification and quantification. This enables future research to answer the question whether phenolic or alcoholic glucuronidation forms the predominant way of metabolism.
引用
收藏
页码:2105 / 2119
页数:14
相关论文
共 129 条
[1]  
ElSohly MA(2005)Chemical constituents of marijuana: the complex mixture of natural cannabinoids Life Sci 78 539-548
[2]  
Slade D(2016)Cannabis sativa: the plant of the thousand and one molecules Front Plant Sci 7 19-25
[3]  
Andre CM(2006)Cannabinoids in medicine: a review of their therapeutic potential J Ethnopharmacol 105 1-87
[4]  
Hausman J-F(2016)Metabolomics of D9-tetrahydrocannabinol: implications in toxicity Drug Metab Rev 48 80-246
[5]  
Guerriero G(1992)Human hepatic microsomal metabolism of delta 1-tetrahydrocannabinol Drug Metab Dispos 20 241-1419
[6]  
Ben Amar M(2007)Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes Life Sci 80 1415-1141
[7]  
Dinis-Oliveira RJ(1995)Involvement of CYP2C in the metabolism of cannabinoids by human hepatic microsomes from an old woman Biol Pharm Bull 18 1138-1103
[8]  
Bornheim LM(2005)CYP2C-catalyzed delta(9)-tetrahydrocannabinol metabolism: kinetics, pharmacogenetics and interaction with phenytoin Biochem Pharmacol 70 1096-1259
[9]  
Lasker JM(1991)Catalytic activity of cytochrome P450 isozymes purified from rat liver in converting 11-oxo-Delta8-tetrahydrocannabinol to delta8-tetrahydrocannabinol-11-oic acid Biochem Pharmacol 42 1255-411
[10]  
Raucy JL(1993)A cytochrome P450 isozyme having aldehyde oxygenase activity plays a major role in metabolizing cannabinoids by mouse hepatic microsomes Biochem Pharmacol 46 405-625